GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » Beneish M-Score

Avax Technologies (Avax Technologies) Beneish M-Score : 0.00 (As of Jun. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Avax Technologies Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Avax Technologies's Beneish M-Score or its related term are showing as below:

During the past 12 years, the highest Beneish M-Score of Avax Technologies was 0.00. The lowest was 0.00. And the median was 0.00.


Avax Technologies Beneish M-Score Historical Data

The historical data trend for Avax Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies Beneish M-Score Chart

Avax Technologies Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.68 -1.45 -3.32 -3.66 -4.01

Avax Technologies Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -4.01 - - -

Competitive Comparison of Avax Technologies's Beneish M-Score

For the Biotechnology subindustry, Avax Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avax Technologies's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avax Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Avax Technologies's Beneish M-Score falls into.



Avax Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Avax Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.1895+0.528 * 1+0.404 * 6.5714+0.892 * 1.4336+0.115 * 0.8561
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0831+4.679 * -0.216533-0.327 * 5.7664
=-3.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep08) TTM:Last Year (Sep07) TTM:
Total Receivables was $0.04 Mil.
Revenue was 0.2 + 0.096 + 0.12 + 0.318 = $0.73 Mil.
Gross Profit was 0.2 + 0.096 + 0.12 + 0.318 = $0.73 Mil.
Total Current Assets was $0.54 Mil.
Total Assets was $1.37 Mil.
Property, Plant and Equipment(Net PPE) was $0.64 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.29 Mil.
Selling, General, & Admin. Expense(SGA) was $3.66 Mil.
Total Current Liabilities was $3.45 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was -1.871 + -1.873 + -1.933 + -1.7 = $-7.38 Mil.
Non Operating Income was 0 + 0.002 + 0 + 0 = $0.00 Mil.
Cash Flow from Operations was -0.876 + -1.789 + -2.655 + -1.763 = $-7.08 Mil.
Total Receivables was $0.16 Mil.
Revenue was 0.096 + 0.059 + 0.145 + 0.212 = $0.51 Mil.
Gross Profit was 0.096 + 0.059 + 0.145 + 0.212 = $0.51 Mil.
Total Current Assets was $7.99 Mil.
Total Assets was $8.98 Mil.
Property, Plant and Equipment(Net PPE) was $0.81 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.29 Mil.
Selling, General, & Admin. Expense(SGA) was $2.36 Mil.
Total Current Liabilities was $3.94 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.044 / 0.734) / (0.162 / 0.512)
=0.059946 / 0.316406
=0.1895

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.512 / 0.512) / (0.734 / 0.734)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0.541 + 0.638) / 1.367) / (1 - (7.985 + 0.81) / 8.983)
=0.137527 / 0.020928
=6.5714

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.734 / 0.512
=1.4336

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.292 / (0.292 + 0.81)) / (0.286 / (0.286 + 0.638))
=0.264973 / 0.309524
=0.8561

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3.663 / 0.734) / (2.359 / 0.512)
=4.990463 / 4.607422
=1.0831

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 3.453) / 1.367) / ((0 + 3.935) / 8.983)
=2.525969 / 0.43805
=5.7664

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-7.377 - 0.002 - -7.083) / 1.367
=-0.216533

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Avax Technologies has a M-score of -3.19 suggests that the company is unlikely to be a manipulator.


Avax Technologies Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Avax Technologies's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Avax Technologies (Avax Technologies) Business Description

Traded in Other Exchanges
N/A
Address
9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210
Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.
Executives
Carl Spana director PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A director ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines